Shi J, Cheng Z, Lv X, Qiong Wang Q, Ye Z, Qiu H, Zhu M, Feng S, Wang Y, Cheng G. A randomized, double-blind, placebo-controlled phase 1b study to evaluate the safety, tolerability, and pharmacodynamics of an anti-amyloid-β antibody SHR-1707 in patients with mild cognitive impairment and mild Alzheimer’s disease. Alzheimer's Association, 25 December 2023 Alzheimer's Association
Recommends
Please login to recommend the paper.
Comments
No Available Comments
Make a Comment
To make a comment you must login or register.